Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2024 Financial Results and Provides Financial Expectations for 2025
Go back to Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2024 Financial Results and Provides Financial Expectations for 2025| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 161.44 -0.18 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $161.62 | 52 Week High | $58.46 | |||
| Open | $161.62 | 52 Week Low | $31.25 | |||
| Day High | $163.53 | P/E | N/A | |||
| Day Low | $160.42 | EPS | $-0.69 | |||
| Volume | 1,076,139 | |||||
